Program Topic Choices
Screening, Diagnosis, and Treatment of PAH: An Overview
Appropriate for front-line cardiovascular, pulmonary, rheumatology, and primary care clinicians, this comprehensive overview identifies key epidemiologic and pathophysiologic features of PAH; presents the current diagnostic algorithm, highlighting important tests and techniques; summarizes the clinical trial evidence base for approved therapies targeting 3 critical disease pathways; and offers state-of-the-art risk assessment and disease management strategies. View listing of speakers
Integrating Guidelines and Clinical Trial Evidence Into Optimal Collaborative Care for Patients With PAH
Designed for clinicians who screen for or help manage the long-term care of patients with PAH, this presentation highlights key features of the diagnostic and therapeutic decision trees in the initial and long-term evaluation and management of PAH, identifying pivotal tests and assessing the clinical trial evidence base, as well as best practices for optimal collaborative care involving health care professionals on the front line and those at PAH referral centers. View listing of speakers
Pulmonary Hypertension in Patients With Connective Tissue Disease
Of particular value for clinicians who screen or care for patients with or at risk for connective tissue diseases (CTDs), this presentation outlines the epidemiology and prognostic significance of pulmonary hypertension in common CTDs, with a focus on systemic scleroderma and lupus; presents evidence supporting the urgent need for effective screening and early diagnosis of pulmonary complications in these patients; and offers practical strategies for comprehensive diagnosis and treatment of PAH in patients with CTDs. View listing of speakers
The Role of Cardiac Imaging in the Diagnosis and Long-term Management of PAH
Designed for cardiovascular and pulmonary specialists, this presentation reviews the current diagnostic workup for PAH; assesses the benefits and limitations of standard imaging tools such as basic echocardiography and vasodilator testing, as well as newer modalities such as magnetic resonance imaging; demonstrates the core value of right heart catheterization as the diagnostic gold standard; summarizes the benefits and limitations of basic treatment; and outlines the key features of an effective collaborative approach between front-line clinicians and those at referral centers. View listing of speakers
New Concepts and Clinical Controversies in PAH
Designed for cardiopulmonary specialists with extensive PAH experience, this presentation explores newer concepts and clinical controversies in the diagnosis and management of PAH, such as the role of various biomarkers and imaging techniques, the benefits and limitations of combination versus sequential therapy, the relative merits of early diagnosis and more aggressive management versus a more gradual approach, and the strengths and limitations of specific end points in clinical trials and practice. View listing of speakers
DIAMOND SUPPORTER
|
PLATINUM SUPPORTER
|
GOLD SUPPORTER
|
SILVER SUPPORTER
|
| Actelion Pharmaceuticals US, Inc. |
Gilead Sciences, Inc. |
United Therapeutics Corporation |
Bayer HealthCare |
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.